Bolt Invest Information

Bolt Biotherapeutics Welcomes Jakob Dupont, M.D., to its Board of Directors Sep 5, 2024

Rosen Law Firm Advocates for Bolt Biotherapeutics Investors Before Critical Class-Action Deadline Jul 26, 2024